2023. Individuals interested in joining the AACR and sponsoring a clinical trial or late-breaking abstract must submit an application for membership no later than January 3, 2024. Membership questions may be directed
2023. Individuals interested in joining the AACR and sponsoring a clinical trial or late-breaking abstract must submit an application for membership no later than January 3, 2024. Membership questions may be directed
参考资料 [1]Tsuyoshi Terada,et al.T cell receptor-engineered T cell therapy using TCR gene derived from an HLA-A2 hepatoblastoma patient who was completely cured by administration of glypican-3 peptide vaccine.2024.AACR...
参考资料 [1]Fang W,et al.Abstract CT247: Updated efficacy and safety of anti-TROP2 ADC SKB264 (MK-2870) for previously treated advanced NSCLC in Phase 2 study[J].Cancer Research,2024, 84(7_Supplement):CT247-CT2...
2024 AACR 年会将于 2024 年 4 月 5 日 - 10 日在美国加利福尼亚州圣地亚哥会议中心召开。 MCE 展位:NO.749 目前,AACR 官网在线公布了摘要标题,众多中国创新研究成果公布。 本文将汇总 Clinical Trial Abstract Plenary Sessions (临床试验摘要全体会议)、Clinical Trial Abstract Minisymposia (临床试验摘要小型...
2024 AACR:中国双抗ADC们卷起来了? 2023年12月12日,百利天恒宣布将首款EGFR×HER3双抗ADC药物BL-B01D1的除中国大陆外全球权益授权给百时美施贵宝(BMS),潜在总交易额最多将达到84亿美元,打破中国创新药出海授权纪录。 近期,CDE网站显示BL-B01D1拟纳入突破性疗法,用于二线及以上治疗复发性或转移性鼻咽癌患者,...
2024 AACR 美国癌症研究协会(AACR)年会是世界上规模最大的癌症研究会议之一,会议关注肿瘤早期研究和创新进展,汇集肿瘤领域的前沿的研究成果。2024年AACR年会于4月5日-4月10日在美国圣地亚哥盛大召开。 本次大会上,AACR官网已公布部分摘要,包括REGULAR ABSTRACT SESSIONS(定期摘要会议)中Minisymposia和Poster Sessions部分。
根据在2024年AACR年会上发布的一项蛋白质基因组学分析结果,在既往接受奥希替尼治疗后疾病进展的EGFR突变、MET扩增的晚期非小细胞肺癌(NSCLC)患者中,与选择性MET-TKI赛沃替尼(savolitinib)联合安慰剂相比,奥希替尼联合赛沃替尼具有更高的临床活性(摘要号CT251)[1]。
prostate cancer (Neo-Red-P) [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(7_Suppl):Abstract nr ...
链接:https://aacrjournals.org/cancerres/article/84/6_Supplement/1773/735532/Abstract-1773-Deciphering-the-roles-of-germline?searchresult=1 6.题目:Spatial-resolved single-cell analysis of the tumor microenvironment in Alaska Native colorectal cancer patients ...